These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 19888649)

  • 1. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest.
    Rollison DE; Giuliano AR; Risendal BC; Sweeney C; Boulware D; Laronga C; Baumgartner KB; Byers T; Slattery ML
    Breast Cancer Res Treat; 2010 Jun; 121(3):661-9. PubMed ID: 19888649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women.
    Slattery ML; Baumgartner KB; Byers T; Guiliano A; Sweeney C; Herrick J; Curtin K; Murtaugh M; Wolff R
    Cancer Causes Control; 2005 Dec; 16(10):1147-57. PubMed ID: 16215864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
    dos Santos Silva I; Johnson N; De Stavola B; Torres-Mejía G; Fletcher O; Allen DS; Allen NE; Key TJ; Fentiman IS; Holly JM; Peto J
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):449-55. PubMed ID: 16537700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
    Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE
    Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I and mammographic density in four geographic locations: a pooled analysis.
    Maskarinec G; Takata Y; Chen Z; Gram IT; Nagata C; Pagano I; Hayashi K; Arendell L; Skeie G; Rinaldi S; Kaaks R
    Int J Cancer; 2007 Oct; 121(8):1786-92. PubMed ID: 17520679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.
    Rice MS; Tworoger SS; Rosner BA; Pollak MN; Hankinson SE; Tamimi RM
    Breast Cancer Res Treat; 2012 Dec; 136(3):805-12. PubMed ID: 23085768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk.
    Allen NE; Roddam AW; Allen DS; Fentiman IS; Dos Santos Silva I; Peto J; Holly JM; Key TJ
    Br J Cancer; 2005 Apr; 92(7):1283-7. PubMed ID: 15756268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
    Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
    Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum insulin-like growth factor-I and breast cancer.
    Toniolo P; Bruning PF; Akhmedkhanov A; Bonfrer JM; Koenig KL; Lukanova A; Shore RE; Zeleniuch-Jacquotte A
    Int J Cancer; 2000 Dec; 88(5):828-32. PubMed ID: 11072255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
    Schairer C; McCarty CA; Isaacs C; Sue LY; Pollak MN; Berg CD; Ziegler RG
    Horm Cancer; 2010 Apr; 1(2):100-11. PubMed ID: 21761353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
    Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between nutritional factors and insulin-like growth factor-I in premenopausal women of different ethnicity.
    Maskarinec G; Takata Y; Kaaks R
    Eur J Nutr; 2005 Mar; 44(2):105-13. PubMed ID: 15309428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
    Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
    Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
    Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast.
    Bohlke K; Cramer DW; Trichopoulos D; Mantzoros CS
    Epidemiology; 1998 Sep; 9(5):570-3. PubMed ID: 9730040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.